NCT03292393

Brief Summary

The study objective is to build group social norms to improve individual adhere to antihypertensive medications. Financial incentives are provided to individuals contingent upon group behavioral changes. Groups of patients will be formed, and incentivized to interact on a daily basis through social media and participate in a monthly-facilitated meeting at a local clinic. By forming groups, making individual outcomes transparent, and setting financial incentives contingent to group targets, individual decisions are framed within emerging social norms.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Sep 2018

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 13, 2017

Completed
7 months until next milestone

First Posted

Study publicly available on registry

September 25, 2017

Completed
11 months until next milestone

Study Start

First participant enrolled

September 1, 2018

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2019

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2020

Completed
Last Updated

November 7, 2018

Status Verified

November 1, 2018

Enrollment Period

1 year

First QC Date

February 13, 2017

Last Update Submit

November 6, 2018

Conditions

Keywords

HypertensionMedicationAdherence

Outcome Measures

Primary Outcomes (1)

  • Self Assessed Medication Adherence

    Use self reported personal pill count to calculate the Medication Possession Ratio score, this ratio is explained in the protocol and can explain how multiple measurements will be aggregated to arrive at one reported value.

    Monthly over 8 months

Secondary Outcomes (5)

  • Self Assessed Diastolic Blood pressure (mm Hg)

    Monthly over 8 months

  • Automatic measure of Medication Adherence

    Daily over 8 months

  • Self Assessed Systolic Blood pressure (mm Hg)

    Monthly over 8 months

  • Automatic measure of Diastolic Blood pressure (mm Hg)

    Three times over 8 months

  • Automatic measure of Systolic Blood pressure (mm Hg)

    Three times over 8 months

Study Arms (3)

Group Contingency Management

ACTIVE COMPARATOR

During the intervention phase, the Group Contingency Management (GCM) arm will continue to take their hypertensive medication for the four-month period and will receive a randomized phone call once a month to obtain a pill count and a home blood pressure monitoring reading using the HBPM. Participants in the GCM arm will receive a payment after each phone call, dependent on their medication adherence assessment. The GCM arm will also receive an additional payment based on their group's medication adherence.The intervention administered is the Financial Reward and Social Norms.

Behavioral: Financial rewardBehavioral: Social normsDevice: Home Blood Pressure MonitoringDevice: Medication adherence assessment

Individual Contingency Management

ACTIVE COMPARATOR

During the intervention phase, those in the Individual Contingency Management (ICM) arm will also continue to take their hypertensive medication for the four-month period but will receive a payment after each phone call, dependent on their medication adherence assessment.The intervention administered is the Financial Reward.

Behavioral: Financial rewardDevice: Home Blood Pressure MonitoringDevice: Medication adherence assessment

Control Arm

PLACEBO COMPARATOR

During the intervention phase, those in the control arm will be asked to continue to take their hypertensive medication for the four-month period and will receive a randomized phone call once a month to obtain a pill count and a blood pressure reading using the HBPM. Those in the control arm will only be paid for their participation in the study regardless of medication adherence assessment.

Device: Home Blood Pressure MonitoringDevice: Medication adherence assessment

Interventions

In contingency management, financial rewards are contingent upon an individual changing behavior. In our study, financial incentives are contingent upon group behavioral changes.. In the intervention phase participants will be randomly assigned to one of the three treatment arms and they will receive the financial incentive that corresponds to their treatment arm. Data will be collected for four months and all participants will continue receiving a compensation for participation

Group Contingency ManagementIndividual Contingency Management
Social normsBEHAVIORAL

To build social norms the study adds a group component to a contingency management model. In contingency management, financial rewards are contingent upon an individual changing behavior. Social norms are expected to emerge as a result of the designed group contingency management, monthly-facilitated meetings at a local clinic, and daily basis interaction through social media. The intervention will build social norms that improve medication adherence of each member of a group. A three-arm randomize trial is designed to test this hypothesis. Hypertensive patients will be randomly assigned to a group contingency management (GCM) arm, an individual contingency management (ICG) arm, or a control arm.

Group Contingency Management

Participants will be reminded that they will receive and learn how to use a Home Blood Pressure Monitor (HBPM) device that participant will keep for the duration of the study

Control ArmGroup Contingency ManagementIndividual Contingency Management

Participants will be informed that they will receive and learn how to use eCap, a medication event monitoring system that participants will return after completing the study. The project nursing student will count the number of pills the participant currently has and make a record of it on the Data Collection form.The participant will provide the project nursing student with his/her antihypertension prescription records so that the dosage amount and number of pills can be recorded on the Data Collection form.

Also known as: eCap
Control ArmGroup Contingency ManagementIndividual Contingency Management

Eligibility Criteria

Age35 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Person has been diagnosed with essential hypertension for at least a year (no new or recently diagnosed hypertensive patients)
  • Person is currently taking no more than 2 medications
  • Person has taken the same anti-hypertensive medication for at least a year (no recent changes in medication)
  • Person reports not being adherent to anti-hypertensive medication
  • Speaks English or Spanish, currently insured
  • Has access to the Internet
  • Willing to participate in social media, able to go to West Kendall Baptist Hospital
  • Available for the next 8 months

You may not qualify if:

  • Persons with Secondary hypertension
  • Persons with coronary heart disease, cerebrovascular disorders or atrial fibrillation,
  • Persons with rubber allergy, or bedridden, wheelchair bound.
  • Persons who have had a stroke or myocardial infarction within the previous 6 months, are pregnant, or have any serious chronic disease will also be excluded from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

HypertensionMedication Adherence

Interventions

Blood Pressure Monitoring, Ambulatory

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesPatient CompliancePatient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior

Intervention Hierarchy (Ancestors)

Blood Pressure DeterminationDiagnostic Techniques, CardiovascularDiagnostic Techniques and ProceduresDiagnosisMonitoring, AmbulatoryMonitoring, Physiologic

Study Officials

  • Alejandro Arrieta, PhD

    Florida International University

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 13, 2017

First Posted

September 25, 2017

Study Start

September 1, 2018

Primary Completion

September 1, 2019

Study Completion

March 1, 2020

Last Updated

November 7, 2018

Record last verified: 2018-11

Data Sharing

IPD Sharing
Will not share